• Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: U.S.

Fidelity Advisor Biotechnology Fund

+ Add to Watchlist

FBTCX:US

16.80 USD 0.36 2.10%

As of 19:59:59 ET on 04/23/2014.

Snapshot for Fidelity Advisor Biotechnology Fund (FBTCX)

Year To Date: -0.71% 3-Month: -14.37% 3-Year: +30.98% 52-Week Range: 12.81 - 20.98
1-Month: -11.06% 1-Year: +23.75% 5-Year: +27.71% Beta vs MXWO: 1.01

Mutual Fund Chart for FBTCX

No chart data available.
  • FBTCX:US 16.80
  • 1M
  • 1Y
Interactive FBTCX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for FBTCX

Fidelity Advisor Biotechnology Fund is an open-end fund incorporated in the USA. The Fund's objective is capital appreciation. The Fund normally invests at least 80% of assets in securities of companies principally engaged in the research, development, manufacture, and distribution of various biotechnological products, services, and processes.

Inception Date: 12-27-2000 Telephone: 1-877-208-0098
Managers: RAJIV KAUL
Web Site: advisor.fidelity.com

Fundamentals for FBTCX

NAV (on 2014-04-23) 16.80
Assets (M) (on 2014-03-31) 1,528.52
Fund Leveraged N
Minimum Investment 2,500.00
Minimum Subsequent Investment 0.00

Dividends for FBTCX

Dividend Type Long Term Cap Gain
Dividend Frequency Semi-Anl
Last Dividend Net (on 2013-12-13) 0.05
Dividend Yield (ttm) 0.31

Fees & Expenses for FBTCX

Front Load 0.00
Back Load 1.00
Current Mgmt Fee 0.55
Redemption Fee 0.75
12b1 Fee 1.00
Expense Ratio 1.87

Top Fund Holdings for FBTCX

Filing Date: 02/28/2014
Name Position Value % of Total
Gilead Sciences Inc 2,790,128 230,994,697 13.703%
Amgen Inc 1,341,968 166,430,871 9.873%
Biogen Idec Inc 324,056 110,399,398 6.549%
Celgene Corp 555,523 89,300,322 5.298%
Alexion Pharmaceuticals Inc 448,244 79,249,539 4.701%
Intercept Pharmaceuticals Inc 168,060 68,988,630 4.093%
Regeneron Pharmaceuticals Inc 185,278 61,604,935 3.655%
Vertex Pharmaceuticals Inc 632,889 51,175,405 3.036%
BioMarin Pharmaceutical Inc 497,438 40,292,478 2.390%
Incyte Corp Ltd 445,974 28,658,289 1.700%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil